JosephCharlesVaglioJr.MD
Cardiology • Topeka, KSAdult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Physician
Are you Dr. Vaglio?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 73 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
929 SW Mulvane St
Topeka, KS 66606Phone+1 785-270-4100Fax+1 785-270-4202
Summary
- Dr. Joseph Vaglio Jr., MD is a cardiologist in Topeka, Kansas. He is currently licensed to practice medicine in Kansas, Missouri, and North Carolina. He is affiliated with Stormont Vail Health.
Education & Training
Vanderbilt University Medical CenterFellowship, Clinical Cardiac Electrophysiology, 2010 - 2011- Vanderbilt University Medical CenterFellowship, Cardiovascular Disease, 2007 - 2010
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2004 - 2007
University of Kansas School of MedicineClass of 2004
Certifications & Licensure
KS State Medical License 2018 - 2025
AZ State Medical License 2013 - 2021
MO State Medical License 2017 - 2020
NC State Medical License 2017 - 2018
TX State Medical License 2011 - 2014
TN State Medical License 2007 - 2012
MN State Medical License 2005 - 2007- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 66 citationsA Common β1-Adrenergic Receptor Polymorphism Predicts Favorable Response to Rate-Control Therapy in Atrial FibrillationBabar Parvez, Nagesh Chopra, Shane Rowan, Joseph Vaglio, Raafia Muhammad
Journal of the American College of Cardiology. 2012-01-03 - 45 citationsClinical characteristics and outcomes of patients with hypertrophic cardiomyopathy with latent obstruction.Joseph C. Vaglio, Steve R. Ommen, Rick A. Nishimura, A. Jamil Tajik, Bernard J. Gersh
American Heart Journal. 2008-08-01 - 100 citationsSymptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation.Babar Parvez, Joseph Vaglio, Shane Rowan, Raafia Muhammad, Gayle Kucera
Journal of the American College of Cardiology. 2012-08-07
Professional Memberships
- Member
